Celldex Therapeutics Inc (NAS:CLDX)
$ 36.92 0.6 (1.65%) Market Cap: 2.43 Bil Enterprise Value: 1.61 Bil PE Ratio: 0 PB Ratio: 2.90 GF Score: 62/100

Celldex Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 18, 2020 / 01:00PM GMT
Release Date Price: $10.38 (-3.89%)
Operator

Good morning. Sarah Cavanaugh from Celldex will open the meeting. Sarah?

Sarah Cavanaugh
Celldex Therapeutics, Inc. - SVP of Corporate Affairs & Administration

Welcome to the Annual Meeting of Stockholders of Celldex Therapeutics being held this year by remote communication. Please note that any nonhistorical statements the company will make today will constitute forward-looking statements under the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from those statements as a result of a number of risks and uncertainties, including the risks that Celldex has cited in its most recent 10-K and 10-Q filings with the Securities and Exchange Commission and that Celldex typically cites in its press releases.

Also, I would like to remind everyone that this meeting is not a public forum for the purposes of the SEC's regulation FD. As a result, while we will provide you with general background information about Celldex, we will not be providing any material nonpublic information at this meeting. I now turn the meeting

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot